1.PLATELET AGGREGATION, FACTOR VIII-RELATED ANTIGEN IN NIDDM PATIENTS
Chinese Journal of Endocrinology and Metabolism 1985;0(02):-
Platelet aggregation, plasma factor Ⅷ-related antigen (Ⅷ R:Ag) and fibrinogen were measured in 23 newly diagnosed diabetic patients after two weeks on diet alone, and at the 2nd, 4th and 6th month during treatment with glipizide. 9 of the 23 patients had microangiopathy and the other 14 had not. On diet alone, the maximal platelet aggregation in diabetic subjects was increased significantly in response to various concentrations of adenosine diphos-phate or adrenaline as compared with those in normal controls (P
2.Relationship between homocysteine and incipient diabetic nephropathy in type 2 diabetes mellitus
Ximei ZHI ; Yiquan LIANG ; Yibin XIAO
Chinese Journal of Diabetes 1994;0(01):-
Objective To investigate the relationship between Homocysteine (Hcy) and incipient diabetic nephropathy in type 2 diabetes mellitus (DM).Methods The plasma Hcy level was measured by high performance liquid chromatography with fluorescence detection in 67 patients with type 2 DM and 47 control persons,the plasma thrombomodulin(sTM),folate and vitamin B 12 were determined simultaneously.Results The plasma Hcy level was higher in type 2 DM patients than that in control subjects (15.27?6.04?mol/L vs 12.10?1.86?mol/L, P
3.Early identification of familial hypertrophic cardiomyopathy mutation gene carriers by constructing Nomogram prediction model based on parametric characteristics of two-dimensional transthoracic echocardiography and three-dimensional speckle tracking imaging
Yiquan DUAN ; Qingqing LIANG ; Yanping XU ; Jingjing YE ; Fang WANG ; Xuan HUANG ; Liming WANG ; Lisha NA
Chinese Journal of Ultrasonography 2023;32(9):773-781
Objective:To explore the characteristics of echocardiographic parameters among the many parameters of two-dimensional transthoracic echocardiography(2D-TTE) and three-dimensional speckle tracking imaging (3D-STI) that can be used for early identification of familial hypertrophic cardiomyopathy(FHCM) mutation gene carriers, and construct a Nomogram prediction model, in order to provide a diagnostic method for early identification of G+ P- patients for clinical practice.Methods:A total of 15 FHCM families admitted to the General Hospital of Ningxia Medical University from November 2017 to August 2022 were enrolled.Whole exome sequencing and Sanger sequencing technology were used for gene detection, among which 54 were G+ P- and 75 were G-P-. Stratified random sampling was used to divide the subjects into training set ( n=90) and test set ( n=39) according to the ratio of 7∶3. Philips iE33 ultrasonic diagnostic instrument and TomTec offline software were used to obtain relevant ultrasonic parameters. Lasso regression and Logistic regression were used to screen echocardiographic parameters and obtain independent risk factors for early prediction of G+ P-, based on which a Nomogram prediction model was established. Results:①Lasso-Logistic regression showed that global longitudinal strain(GLS) ( OR=1.739, 95% CI=1.305-2.316) and left ventricular outflow trac velocity time integral(LVOT-VTI) ( OR=1.358, 95% CI=1.072-1.722) could be used as independent risk factors for early prediction of G+ P-. ②The Nomogram prediction model was established based on the above indicators. After 1000 internal verifications of Bootstrap self-sampling, the C-indices of the training set and the test set were 0.885 (95% CI=0.816-0.954), 0.878 (95% CI=0.764-0.992), which had good internal consistency. ③The results of the calibration curve showed that the risk of G+ P- predicted by the Nomogram model was basically consistent with the actual risk (training set P=0.990, test set P=0.961); the clinical decision curve shows that under different threshold probabilities, using this prediction model to provide patients with clinical decision-making could bring benefits to patients. Conclusions:Echocardiographic parameters GLS and LVOT-VTI can be used as independent risk factors to predict FHCM mutation gene carriers. The Nomogram prediction model has good discrimination, goodness of fit and clinical benefit in identifying whether the family members of FHCM patients carry the mutation gene, and it can provide a new idea and evaluation method for the early identification of FHCM mutation gene carriers by echocardiography.
4.Intraoperative CT in endoscopic endonasal surgery for pituitary adenomas
Liang FENG ; Yizhao CHEN ; Mouxuan DU ; Rui DING ; Zhenghao FU ; Shizhong ZHANG ; Yiquan KE
Chinese Journal of Neuromedicine 2014;13(4):375-378
Objective To explore the value ofintraoperative CT (iCT) in endoscopic endonasal surgery for pituitary adenomas.Methods A retrospective analysis was conducted in the clinical data of 37 patients with pituitary adenomas performed endoscopic endonasal surgery with assistance of iCT in our hospital from November 2012 to June 2013.The influences of iCT on surgical process and results were analyzed.Results Intraoperative scanning was performed 1 to 3 times in each patient,averaging 1.43 times.The scanning time was only 50-60 s.Among the 37 patients,iCT revealed residual tumor in 11,9 of which underwent further resection with total removal in 6 and subtotal in 3,and the tumors in the other two patients were unable to be resected because the adenomas were tenacious and adhered closely to the internal carotid artery.Finally,the rate of gross total removal increased from 70.3% to 86.5%,rising by 16.2%.No iCT related complications and severe surgical complication occurred.Conclusion The application of iCT in endoscopic endonasal surgery for pituitary adenomas provides objective evidence for the guidance of surgical procedure and real-time judgment of surgical results,which not only leads to higher percentage of tumor removal but also eliminates the unnecessary blind surgical manipulation to increase the safety of the operation.